Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Marini

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Journal of Chromatography. A|June 28, 2011
Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design spaceB Debrus, P Lebrun, J Mbinze Kindenge, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 20, 2010
Reliable low-cost capillary electrophoresis device for drug quality control and counterfeit medicinesR D Marini, E Rozet, M L A Montes, et al.
Current Drug Safety|June 20, 2017
Detection of Poor Quality Artemisinin-based Combination Therapy (ACT) Medicines Marketed in Benin Using Simple and Advanced Analytical TechniquesAchille Yemoa, Vedaste Habyalimana, Jeremie K Mbinze, et al.
Journal of Chromatography. A|October 11, 2012
Application of an innovative design space optimization strategy to the development of liquid chromatographic methods to combat potentially counterfeit nonsteroidal anti-inflammatory drugsJ K Mbinze, P Lebrun, B Debrus, et al.
Sarcoma|March 28, 2013
Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma CellsJason E Cain, Andrew McCaw, W Samantha N Jayasekara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid TumorsAndrea Muscat, Dean Popovski, W Samantha N Jayasekara, et al.
Nature Communications|July 5, 2023
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinomaKaja Kostyrko, Marta Román, Alex G Lee, et al.
Plos One|October 3, 2013
Next-generation sequence analysis of cancer xenograft modelsFernando J Rossello, Richard W Tothill, Kara Britt, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 26, 2016
Fingerprinting and validation of a LC-DAD method for the analysis of biflavanones in Garcinia kola-based antimalarial improved traditional medicinesP Tshisekedi Tshibangu, P Mutwale Kapepula, M J Kabongo Kapinga, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 7, 2021
MRI characterization of hemodynamic patterns of human fetuses with cyanotic congenital heart diseaseL Sun, J F P van Amerom, D Marini, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Journal of Chromatography. A|June 28, 2011
Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design spaceB Debrus, P Lebrun, J Mbinze Kindenge, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 20, 2010
Reliable low-cost capillary electrophoresis device for drug quality control and counterfeit medicinesR D Marini, E Rozet, M L A Montes, et al.
Current Drug Safety|June 20, 2017
Detection of Poor Quality Artemisinin-based Combination Therapy (ACT) Medicines Marketed in Benin Using Simple and Advanced Analytical TechniquesAchille Yemoa, Vedaste Habyalimana, Jeremie K Mbinze, et al.
Journal of Chromatography. A|October 11, 2012
Application of an innovative design space optimization strategy to the development of liquid chromatographic methods to combat potentially counterfeit nonsteroidal anti-inflammatory drugsJ K Mbinze, P Lebrun, B Debrus, et al.
Sarcoma|March 28, 2013
Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma CellsJason E Cain, Andrew McCaw, W Samantha N Jayasekara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid TumorsAndrea Muscat, Dean Popovski, W Samantha N Jayasekara, et al.
Nature Communications|July 5, 2023
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinomaKaja Kostyrko, Marta Román, Alex G Lee, et al.
Plos One|October 3, 2013
Next-generation sequence analysis of cancer xenograft modelsFernando J Rossello, Richard W Tothill, Kara Britt, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 26, 2016
Fingerprinting and validation of a LC-DAD method for the analysis of biflavanones in Garcinia kola-based antimalarial improved traditional medicinesP Tshisekedi Tshibangu, P Mutwale Kapepula, M J Kabongo Kapinga, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 7, 2021
MRI characterization of hemodynamic patterns of human fetuses with cyanotic congenital heart diseaseL Sun, J F P van Amerom, D Marini, et al.
Pageof 10